Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR51M1 Inhibitors

OR51M1 Inhibitors represent a class of compounds that aim to modulate the signaling of the OR51M1 olfactory receptor. Given the inherent nature of olfactory receptors being GPCRs, they signal primarily via G-proteins. This characteristic is clearly demonstrated by the range of inhibitors that target G-protein pathways, from Pertussis Toxin's inhibition of Gi/o types to NF023's broader antagonistic effects on G-proteins. By the activation or efficient signaling of these G-proteins, a cascading effect on OR51M1 signaling can be instigated. Furthermore, the list extends to other indirect modulators that intervene with pathways downstream of GPCR signaling. Compounds such as Chelerythrine chloride and Go 6983 target protein kinase C, an enzyme known to be a part of various signaling cascades, including those associated with GPCRs. The inclusion of modulators like Ionomycin and W-7 hydrochloride, which influence intracellular calcium dynamics, reflects the multifaceted interplay in GPCR signaling, with calcium serving as a crucial secondary messenger. Overall, the range of OR51M1 inhibitors highlights the receptor's intricate signaling network and offers avenues to modulate its activity indirectly through the perturbation of associated pathways.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$442.00
3
(1)

Pertussis Toxin inhibits Gi/o type G-proteins, which can affect OR51M1 signaling.

NF 023

104869-31-0sc-204124
sc-204124A
10 mg
50 mg
$158.00
$617.00
1
(1)

NF023 is a non-selective antagonist of G-proteins, and can modulate OR51M1 signaling.

Guanosine 5′-O-(2-Thiodiphosphate) trilithium salt

97952-36-8sc-295029
sc-295029A
1 mg
5 mg
$133.00
$173.00
2
(1)

GDP-β-S can inhibit G-proteins by preventing their activation, potentially affecting OR51M1-mediated pathways.

ML 141

71203-35-5sc-362768
sc-362768A
5 mg
25 mg
$134.00
$502.00
7
(1)

ML 141 selectively inhibits Cdc42 GTPase, which can influence downstream pathways of OR51M1.

YM 254890

568580-02-9sc-507356
1 mg
$500.00
(0)

YM-254890 specifically inhibits Gq/11 type G-proteins, affecting pathways that OR51M1 might be involved in.

Chelerythrine chloride

3895-92-9sc-3547
sc-3547A
5 mg
25 mg
$88.00
$311.00
17
(1)

Chelerythrine chloride inhibits protein kinase C, which can impact downstream processes of OR51M1.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$76.00
$265.00
80
(4)

Ionomycin elevates intracellular calcium, potentially modulating OR51M1 signaling dynamics.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$103.00
$293.00
$465.00
15
(1)

Go 6983 inhibits protein kinase C, potentially affecting the OR51M1 signaling pathway.

W-7

61714-27-0sc-201501
sc-201501A
sc-201501B
50 mg
100 mg
1 g
$163.00
$300.00
$1642.00
18
(1)

W-7 hydrochloride inhibits calmodulin, which may affect calcium-mediated processes linked to OR51M1.